Home  >  News
you can get e-magazine links on WhatsApp.Click here
Corporate + Font Resize -

Venus gets GMP approval from Ukraine for all its nine manufacturing facilities

Our Bureau, Bengaluru
Monday, July 22, 2013, 14:35 Hrs  [IST]

Venus Remedies Limited has received good manufacturing practices (GMP) approval for all its nine manufacturing facilities from Ukraine, a Pharmaceutical Inspection Convention/ Cooperation Scheme (PIC/S) member nation.

“We are the only Indian company to get Ukrainian GMP approval for large volume parenterals for its Panchkula plant in Haryana. The certification was granted by the National Agency for Food and Drug Administration and Control (NAFDAC), Ukraine after three rounds of audit,” said Dr Manu Chaudhary, joint managing director, Venus Remedies Ltd and director, Research, Venus Medicine Research Centre (VMRC).

The nine facilities cater to the manufacture of cephalosporin injection, carbepenem, oncology liquid injection, oncology lyophilised injection, ampoules, liquid vials, general lyophilised vials, prefilled syringes and intravenous (IV) fluids.

Dr Chaudhary, said, that the certification is an extended recognition for our manufacturing facilities, which are on a par with international standards in terms of the quality system set by PIC/S member nations. This is the third time that we have got a PIC/S recognition for quality manufacturing standards. Now, all the nine facilities of Venus, eight in Baddi and one in Panchkula, are certified with GMP by the NAFDAC, Ukraine, thereby opening more opportunities for Venus to expand its product portfolio in the remaining PIC/S member countries.

With a population of 46.6 million, Ukraine is one of the largest countries in Europe, thus making it a potentially lucrative pharmaceutical market. The pharmaceutical market in Ukraine is expanding at a rapid pace. The US$ 3 billion market is expected to grow at a compound annual growth rate (CAGR) of 16 per cent. India is the second largest exporter of pharmaceutical products to Ukraine after Germany.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |